Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

被引:32
|
作者
Hulot, J. -S. [1 ,2 ,3 ]
Wuerzner, G. [4 ]
Bachelot-Loza, C. [5 ]
Azizi, M. [4 ,6 ]
Blanchard, A. [4 ]
Peyrard, S. [4 ]
Funck-Brentano, C. [1 ,2 ,3 ]
Gaussem, P. [5 ,6 ,7 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, Serv Pharmacol, Unite Pharmacogenet,Ctr Invest Biomed, F-75013 Paris, France
[2] Univ Paris, UPMC, Paris, France
[3] INSERM, UMR S 956, Paris, France
[4] Hop Europeen Georges Pompidou, AP HP, Ctr Invest Clin, INSERM,CIC 9201, Paris, France
[5] INSERM, UMR S 765, Fac Pharm, Paris, France
[6] Univ Paris 05, Paris, France
[7] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France
关键词
OF-FUNCTION POLYMORPHISM;
D O I
10.1111/j.1538-7836.2009.03729.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:610 / 613
页数:4
相关论文
共 50 条
  • [31] RANDOMISED COMPARISON OF ADJUNCTIVE NAOXINTONG VERSUS STANDARD MAINTENANCE DOSE CLOPIDOGREL IN PATIENTS WITH CYP2C19*2 GENE MUTATION
    Chen, Hui
    HEART, 2011, 97
  • [32] INTERACTION BETWEEN 2C19*2 GENE POLYMORPHISM, CYP3A4-METABOLYZED STATINS AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL
    Nadeau, P. L.
    Dery, J.
    Dery, U.
    Rinfret, S.
    Larose, E.
    Barbeau, G.
    Nguyen, C. M.
    Gleeton, O.
    Proulx, G.
    Noel, B.
    Roy, L.
    De Larochelliere, R.
    Tizon-Marcos, H.
    Rodes-Cabau, J.
    Tricoci, P.
    Becker, R. C.
    Bertrand, O. F.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 50D - 51D
  • [33] Optimizing clopidogrel dose response: a new clinical algorithm comprising CYP2C19 pharmacogenetics and drug interactions
    Saab, Yolande B.
    Zeenny, Rony
    Ramadan, Wijdan H.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1421 - 1427
  • [34] Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome
    Cuisset, Thomas
    Quilici, Jacques
    Cohen, William
    Fourcade, Laurent
    Saut, Noemie
    Pankert, Mathieu
    Gaborit, Benedicte
    Carrieri, Maria Patrizia
    Morange, Pierre-Emmanuel
    Bonnet, Jean Louis
    Alessi, Marie-Christine
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (06): : 760 - 765
  • [35] Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects
    Song, Bai-Li
    Wan, Meng
    Tang, Dan
    Sun, Chao
    Zhu, Yu-Bing
    Linda, Nyame
    Fan, Hong-Wei
    Zou, Jian-Jun
    CLINICAL THERAPEUTICS, 2018, 40 (07) : 1170 - 1178
  • [36] A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism
    Chen Hui
    Wu Xiao-ying
    Wu Hong-xia
    Wang Huan
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2014, 20 (12) : 894 - 902
  • [37] Genetic polymorphisms of CYP2C19 and effect of CYP2C19☆2 allele on clopidogrel P2Y12 inhibition in healthy Malaysian volunteers
    Sani, Y. N.
    Lim, S. C.
    Lim, L. H.
    Edwin, N. E. Y.
    Khan, N. Abdul Karim
    Goh, T. H.
    Serebruany, V. L.
    Yuen, K. H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 874 - 874
  • [38] A Randomized Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Clopidogrel in Three Different CYP2C19 Genotype Groups of Healthy Japanese Subjects
    Kobayashi, Masahiko
    Kajiwara, Miyuki
    Hasegawa, Setsuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (11) : 1186 - 1196
  • [39] Comparison of loading with maintenance dose of clopidogrel on platelet reactivity in Chinese with different CYP2C19 genotypes prior to percutaneous coronary intervention
    Zhang Xiaoxing
    Yan Lirong
    Wang Dongxue
    Li Yan
    Han Lulu
    Tian Lei
    Liu Hong
    Li Yishi
    中华医学杂志(英文版), 2014, (14) : 2571 - 2577
  • [40] Comparison of loading with maintenance dose of clopidogrel on platelet reactivity in Chinese with different CYP2C19 genotypes prior to percutaneous coronary intervention
    Zhang Xiaoxing
    Yan Lirong
    Wang Dongxue
    Li Yan
    Han Lulu
    Tian Lei
    Liu Hong
    Li Yishi
    CHINESE MEDICAL JOURNAL, 2014, 127 (14) : 2571 - 2577